How to Value an Urgent Care Chain (Multi-Location Operators)

Single-site urgent care centers sell at 5-7x EBITDA and attract physician buyers or small health system tuck-ins. Multi-location urgent care chains — three or more sites with centralized operations — play in an entirely different market. At 8-12x EBITDA, these are institutional-grade assets that attract PE firms, national platforms, and strategic health system acquirers.

I've been involved in urgent care transactions at both ends of this spectrum, and the valuation gap between a well-run chain and a collection of loosely connected clinics is enormous. The difference comes down to infrastructure, not just location count.

What Makes an Urgent Care Chain vs. a Group of Clinics

Owning four urgent care locations doesn't make you a chain. I see physician groups that own multiple sites where each location runs its own billing, uses a different EHR, has different hours, and the "corporate office" is the founder's dining room table. That's a collection of clinics. Buyers pay collection-of-clinics multiples.

A true urgent care chain has centralized revenue cycle management, standardized clinical protocols, unified branding, a single EHR across all sites, centralized credentialing, and a management layer that operates independently of any single provider. When CityMD sold to Summit Health for a deal that implied roughly $7B in enterprise value across the combined platform, they weren't buying a group of walk-in clinics. They were buying a brand, a system, and a patient acquisition engine.

The Metrics That Drive Urgent Care Chain Valuation

Patient volume per location per day. This is the fundamental throughput metric. A healthy urgent care site sees 35-60 patients per day. Top performers in dense urban markets (CityMD in Manhattan, MedExpress in mid-Atlantic metros) can exceed 80. Below 25 patients/day, a site is likely unprofitable or marginal. Buyers model volume at the site level and will discount or exclude underperforming locations from the EBITDA base.

Same-store patient volume growth.Just like retail, same-store growth separates good operators from great ones. If your existing locations are growing patient volume 3-8% annually, you're demonstrating organic demand. Flat or declining same-store volume — even if total volume is growing through new sites — raises questions about market saturation and competitive pressure.

Revenue per visit.Average revenue per patient visit in urgent care typically runs $150-250 for standard visits, but the mix matters enormously. Occupational health visits (drug screens, physicals, workers' comp injuries) often generate $200-400 per visit. Employers pay higher rates, payment is reliable, and the volume is contractually committed. An urgent care chain with 30-40% occupational health revenue is worth meaningfully more than one that's 100% walk-in consumer.

The occupational health contract portfolio. This deserves its own emphasis. Occupational health contracts with local employers — pre-employment physicals, drug testing, injury treatment, DOT exams — create a recurring, predictable revenue stream that is largely recession-resistant. Companies like Concentra (owned by Select Medical) built billion-dollar platforms primarily on occupational health. If your chain has 50-100 active employer contracts, that portfolio alone has significant standalone value.

Provider staffing model.This is where urgent care chains diverge strategically. Some chains staff exclusively with physicians (MD/DO). Others use nurse practitioners and physician assistants (NP/PA) as the primary providers, with physician oversight. The NP/PA model runs at significantly lower labor cost — $130K-170K annual compensation vs. $250K-350K for emergency medicine physicians — and in many states, NPs practice independently. American Family Care and GoHealth Urgent Care both run NP/PA-forward models successfully. Buyers evaluate the staffing model for both margin impact and scalability — it's easier to recruit NPs than board-certified emergency medicine physicians.

Geographic Density and Market Strategy

The most valuable urgent care chains are geographically dense within specific metro areas rather than spread thinly across multiple markets. Density drives three things that directly impact valuation:

Brand recognition. When patients in a metro area know your name, your patient acquisition cost drops. CityMD in New York, MedExpress in the mid-Atlantic, and GoHealth in the Pacific Northwest all benefit from regional brand density that reduces marketing spend per patient.

Provider float. With multiple locations in a metro, you can move providers between sites to cover call-outs, manage seasonal volume spikes, and optimize staffing without relying on expensive locum tenens. This operational flexibility directly improves margins.

Payor leverage. A chain that sees 15-20% of the urgent care volume in a metro area has genuine negotiating leverage with commercial insurance payors. Single sites take whatever rate the payor offers. Chains negotiate.

Technology and Operational Infrastructure

Buyers in 2026 expect operational sophistication. The technology stack matters:

• Single EHR platform: All locations on the same system with centralized reporting. If three of your sites run athenahealth and two run eClinicalWorks, that's a post-close integration project the buyer will price in.
• Online check-in and wait time transparency: Patient-facing technology that drives volume. Chains with online scheduling and real-time wait time displays consistently see higher patient satisfaction and volume.
• Revenue cycle management: Centralized billing with clean claims rates above 95% and days in A/R under 30. Fragmented billing is one of the most common margin destroyers in urgent care.
• Business intelligence: Site-level P&L reporting, provider productivity dashboards, and patient mix analytics. Buyers want to see that management uses data, not gut instinct.

The Hospital System Partnership Model

Not every urgent care exit is a PE transaction. Hospital systems are increasingly active acquirers of urgent care chains for a strategic reason: patient capture. An urgent care visit is often the entry point for a patient into a health system's network. The patient who comes in for a sprained ankle gets referred to an orthopedist, gets imaging at the system's radiology center, and becomes a primary care patient.

Hospital systems will sometimes pay premium multiples (10-14x EBITDA) for chains in their service area because they're not just buying the urgent care EBITDA — they're buying downstream referral volume worth multiples of the urgent care revenue. MedExpress was acquired by Optum (UnitedHealth Group) partly for this downstream capture dynamic within Optum's growing care delivery platform.

If you're a chain operator considering a sale, running a process that includes both PE firms and local health systems often produces the best outcome. The competitive tension between financial and strategic buyers drives price.

What Kills Value in Urgent Care Chain Transactions

The four issues I see most frequently derail urgent care valuations:

• Provider dependency: If the founder-physician still sees 40% of total patient volume, the chain isn't a platform — it's a practice with satellites. Buyers discount heavily for this.
• Lease concentration: Multiple sites with leases expiring within 2-3 years creates existential risk. Secure long-term leases before going to market.
• Credentialing gaps: Providers who aren't credentialed with major payors at every location. This seems like a small issue until the buyer discovers they can't bill Blue Cross at two of your seven sites.
• Malpractice history: Urgent care has inherent clinical risk (missed diagnoses, procedural complications). A pattern of malpractice claims, even if settled, will trigger extensive diligence and potentially reduce the buyer pool.

The Bottom Line

Multi-location urgent care is a genuine platform opportunity in healthcare M&A. The gap between a single-site multiple and a chain multiple is wide enough to justify the investment in building real operational infrastructure. If you operate three or more locations with centralized operations, strong patient volume, and an occupational health contract portfolio, you're holding an asset that PE firms and health systems are actively seeking. The key is ensuring your operations match your ambitions — buyers at 8-12x EBITDA expect institutional-quality businesses, and they diligence accordingly.